A/Prof David van der Poorten
A/Prof David van der Poorten
University of Sydney at Westmead Hospital
Verified email at sydney.edu.au - Homepage
Title
Cited by
Cited by
Year
Visceral fat: a key mediator of steatohepatitis in metabolic liver disease
D van der Poorten, KL Milner, J Hui, A Hodge, MI Trenell, JG Kench, ...
Hepatology 48 (2), 449-457, 2008
5592008
The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study
N Bhala, P Angulo, D van der Poorten, E Lee, JM Hui, G Saracco, ...
Hepatology 54 (4), 1208-1216, 2011
4592011
Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease
KL Milner, D van der Poorten, A Xu, E Bugianesi, JG Kench, KSL Lam, ...
Hepatology 49 (6), 1926-1934, 2009
1912009
Complex non‐invasive fibrosis models are more accurate than simple models in non‐alcoholic fatty liver disease
LA Adams, J George, E Bugianesi, E Rossi, WB De Boer, ...
Journal of gastroenterology and hepatology 26 (10), 1536-1543, 2011
1722011
Chronic hepatitis C is associated with peripheral rather than hepatic insulin resistance
KL Milner, D van der Poorten, M Trenell, AB Jenkins, A Xu, G Smythe, ...
Gastroenterology 138 (3), 932-941. e3, 2010
1632010
Hepatic fat loss in advanced nonalcoholic steatohepatitis: are alterations in serum adiponectin the cause?
D van der Poorten, CF Samer, M Ramezani‐Moghadam, S Coulter, ...
Hepatology 57 (6), 2180-2188, 2013
1182013
Twenty‐year audit of percutaneous liver biopsy in a major Australian teaching hospital
D Van der Poorten, A Kwok, T Lam, L Ridley, DB Jones, MC Ngu, AU Lee
Internal medicine journal 36 (11), 692-699, 2006
1072006
MBOAT7 rs641738 increases risk of liver inflammation and transition to fibrosis in chronic hepatitis C
K Thabet, A Asimakopoulos, M Shojaei, M Romero-Gomez, A Mangia, ...
Nature communications 7 (1), 1-8, 2016
882016
Diverse impacts of the rs58542926 E167K variant in TM6SF2 on viral and metabolic liver disease phenotypes
M Eslam, A Mangia, T Berg, HLY Chan, WL Irving, GJ Dore, ML Abate, ...
Hepatology 64 (1), 34-46, 2016
812016
The effectiveness of rifabutin triple therapy for patients with difficult‐to‐eradicate Helicobacter pylori in clinical practice
D Van der Poorten, PH Katelaris
Alimentary pharmacology & therapeutics 26 (11‐12), 1537-1542, 2007
812007
Visceral adiposity in gastrointestinal and hepatic carcinogenesis
R Vongsuvanh, J George, L Qiao, D van der Poorten
Cancer letters 330 (1), 1-10, 2013
632013
Visceral adiposity index is not a predictor of liver histology in patients with non-alcoholic fatty liver disease
R Vongsuvanh, J George, D McLeod, D van der Poorten
Journal of hepatology 57 (2), 392-398, 2012
602012
Hepatitis C virus induces the cannabinoid receptor 1
D Van Der Poorten, M Shahidi, E Tay, J Sesha, K Tran, D McLeod, ...
PLoS One 5 (9), e12841, 2010
502010
Adiponectin reduces hepatic stellate cell migration by promoting tissue inhibitor of metalloproteinase-1 (TIMP-1) secretion
M Ramezani-Moghadam, J Wang, V Ho, TJ Iseli, B Alzahrani, A Xu, ...
Journal of Biological Chemistry 290 (9), 5533-5542, 2015
472015
Oily fish, coffee and walnuts: Dietary treatment for nonalcoholic fatty liver disease
V Gupta, XJ Mah, MC Garcia, C Antonypillai, D van der Poorten
World Journal of Gastroenterology: WJG 21 (37), 10621, 2015
422015
Midkine increases diagnostic yield in AFP negative and NASH-related hepatocellular carcinoma
R Vongsuvanh, D van der Poorten, T Iseli, SI Strasser, GW McCaughan, ...
PloS one 11 (5), e0155800, 2016
402016
Liver disease in adolescents: A cohort study of high‐risk individuals
D Van der Poorten, DT Kenny, T Butler, J George
Hepatology 46 (6), 1750-1758, 2007
392007
The gut microbiome
M Sidhu, D van der Poorten
Australian family physician 46 (4), 206-211, 2017
382017
Disease-specific mechanisms of fibrosis: hepatitis C virus and nonalcoholic steatohepatitis
D van der Poorten, J George
Clinics in liver disease 12 (4), 805-824, 2008
342008
Intraduodenal levodopa-carbidopa intestinal gel infusion improves both motor performance and quality of life in advanced Parkinson’s disease
FCF Chang, V Kwan, D van der Poorten, N Mahant, N Wolfe, AD Ha, ...
Journal of Clinical Neuroscience 25, 41-45, 2016
322016
The system can't perform the operation now. Try again later.
Articles 1–20